“The idea was really to bring together a multidisciplinary group of experts and to discuss…highly relevant, translational research that’s going on, and to…address some of the really critical clinical questions as well,” says Seth P. Lerner, MD, FACS.
In this video, Seth P. Lerner, MD, FACS, discusses the key points of the bladder cancer course presented recently at the 2021 Society of Urologic Oncology Annual Meeting. Lerner is a professor of urology, Beth and Dave Swalm Chair in urologic oncology, director of urologic oncology, and director of the Multidisciplinary Bladder Cancer Program at the Baylor College of Medicine, Houston, Texas.
Enhancing the quality of bladder cancer care in the community setting
August 5th 2023Suzanne Merrill, MD, recaps the BCAN 2023 Think Tank session she co-chaired that covered prehabilitation programs, urinary diversion management, and other focal areas aimed at enhancing the quality of bladder cancer care in the community.
BCAN session to highlight epigenetics and response to immunotherapy in bladder cancer
August 3rd 2023"I'm really optimistic that the session we are conducting will provide some recommendations [and] some ideas that will help us think about utilizing epigenetic therapies in a very evidence-based way," says Ania Woloszynska, PhD.
2 Clarke Drive
Cranbury, NJ 08512